Buy Yuflyma from Canada

What is Yuflyma?

Yuflyma’s generic name is adalimumab-aaty, and it’s pronounced as “yoo-fly’-mah.” As a TNF (Tumor Necrosis Factor) blocker, Yuflyma plays a crucial role in modulating the immune system. TNF is a protein in the body that contributes to inflammation and is implicated in various autoimmune disorders. By inhibiting TNF, Yuflyma effectively reduces inflammatory responses, which are a hallmark of autoimmune diseases. This mechanism of action positions Yuflyma as a vital therapeutic agent in managing these conditions.

Yuflyma is a significant advancement in the treatment of various autoimmune conditions. It is recognized as a biosimilar to Humira (Adalimumab), one of the most widely used biologic medications in the world. The introduction of Yuflyma offers a more accessible treatment option for patients, maintaining the efficacy and safety profile comparable to that of its reference product, Humira. This development marks a pivotal moment in the healthcare industry, particularly in the realm of affordable biologic therapies.

Medical Uses

Yuflyma is approved for treating a range of autoimmune conditions, each with its unique challenges and impacts on patients’ lives. These include:

1. Rheumatoid Arthritis: Yuflyma helps in reducing pain, swelling, and progression of joint damage in adults with moderate to severe rheumatoid arthritis. It can be used alone or in combination with methotrexate.
2. Juvenile Idiopathic Arthritis: For children aged two years and older, Yuflyma is used to alleviate the symptoms of this form of arthritis, which affects multiple joints.
3. Psoriatic Arthritis: In adults, Yuflyma is effective in managing the symptoms of psoriatic arthritis, a condition that combines skin symptoms of psoriasis with joint inflammation.
4. Ankylosing Spondylitis: This medication is used to reduce the signs and symptoms of this inflammatory disease, primarily affecting the spine and large joints.
5. Crohn’s Disease: Yuflyma is beneficial for adults and children aged six years and older with this inflammatory bowel disease, helping to reduce symptoms and prevent flare-ups.
6. Ulcerative Colitis: In adults with moderate to severe ulcerative colitis, Yuflyma is indicated for inducing and maintaining clinical remission, mucosal healing, and reducing corticosteroid dependence.
7. Plaque Psoriasis: For adults with moderate to severe chronic plaque psoriasis, Yuflyma is used when systemic therapy or phototherapy is necessary.
8. Hidradenitis Suppurativa: Yuflyma treats this chronic skin condition, characterized by small, painful lumps under the skin, in adults.
9. Non-Infectious Uveitis: For adults with non-infectious intermediate, posterior, and panuveitis, Yuflyma helps reduce inflammation and preserve vision.

In each of these conditions, Yuflyma’s role as a TNF blocker is pivotal in reducing inflammation and improving the quality of life for patients.

How Yuflyma Works

Yuflyma operates by targeting and inhibiting the activity of Tumor Necrosis Factor (TNF), a substance in the body’s immune system responsible for inflammation and immune system regulation. TNF plays a critical role in the inflammatory process of autoimmune diseases. In such conditions, the body’s immune system mistakenly attacks its own tissues, leading to inflammation and tissue damage.

Yuflyma binds to TNF molecules, preventing them from interacting with their receptors on cell surfaces. This inhibition blocks the cascade of inflammatory responses triggered by TNF, thereby reducing inflammation and alleviating symptoms associated with autoimmune disorders. By targeting TNF, Yuflyma helps in managing the overactive immune response, making it a valuable treatment for various autoimmune conditions.

Dosage and Administration

Yuflyma is available in two forms: a pre-filled syringe and an auto-injector, providing flexibility and convenience in administration. The dosage and administration of Yuflyma vary depending on the condition being treated:

• Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis: The typical dosage is 40 mg administered every other week.
• Crohn’s Disease, Ulcerative Colitis: The recommended adult induction dose is 160 mg on Day 1, followed by 80 mg at Week 2. Maintenance therapy begins at Week 4 with 40 mg every other week.
• Plaque Psoriasis, Hidradenitis Suppurativa: Dosage may vary, often starting with a higher dose followed by a regular maintenance dose.

Patients or caregivers are trained to administer Yuflyma subcutaneously, usually in the thigh or abdomen. It’s important to rotate the injection site with each dose to avoid skin issues. The medication should be allowed to reach room temperature before injection for patient comfort. Yuflyma is citrate-free, which may reduce injection site discomfort compared to older adalimumab formulations.

Side Effects

Common Side Effects

The most frequently reported side effects of Yuflyma include:

• Injection site reactions (redness, itching, swelling)
• Upper respiratory infections (like colds)
• Headaches
• Nausea
• Rash

These side effects are generally mild and often resolve without needing to discontinue the medication.

Serious Side Effects and Allergic Reactions

Serious side effects, though less common, can include:

• Severe infections such as tuberculosis and fungal infections
• Allergic reactions, which may manifest as hives, difficulty breathing, or swelling of the face
• Neurological symptoms like numbness or tingling, which could indicate nerve problems

Immediate medical attention should be sought if any of these serious side effects occur.

Long-term Risks

Long-term use of Yuflyma may increase the risk of certain serious conditions, including:

• Increased susceptibility to infections due to immune system suppression
• Potential increased risk of developing certain types of cancer, such as lymphoma
• Reactivation of hepatitis B in carriers of the virus

Patients on Yuflyma should be monitored regularly for these risks, and any concerns should be promptly discussed with a healthcare provider.

Warnings and Precautions

Risks Associated with Yuflyma

Yuflyma, like other TNF blockers, carries several risks that require careful consideration:

• Infections: Patients are at an increased risk for serious infections, including tuberculosis, fungal, bacterial, and viral infections. These infections may lead to hospitalization or death.
• Malignancies: There is a potential risk of developing certain types of cancer, such as lymphoma and other malignancies, particularly in children and adolescents.
• Heart Failure: Worsening or new onset of heart failure has been reported.
• Neurological Disorders: Rare cases of neurological disorders, including multiple sclerosis and seizures, have been associated with TNF blockers.
• Autoimmune Reactions: Treatment may result in the formation of autoantibodies and, in rare cases, a lupus-like syndrome.

Conditions Under Which Yuflyma Should Not Be Used

Yuflyma should not be used in patients with:

• Active Tuberculosis: Patients should be tested for TB before starting Yuflyma.
• Severe Infections: Including sepsis, active fungal infections, and other opportunistic infections.
• Known Hypersensitivity: To any component of the product.

Necessary Medical Tests Before and During Treatment

Before initiating treatment with Yuflyma, patients should undergo:

• Screening for Latent Tuberculosis: Using a tuberculin skin test or a TB blood test.
• Tests for Hepatitis B: To prevent reactivation in carriers.
• Regular Monitoring: For signs of infection, malignancy, heart failure, and neurological symptoms.

Interactions with Other Medications

Information on Drug Interactions

Yuflyma can interact with:

• Live Vaccines: Patients should not receive live vaccines while using Yuflyma.
• Other TNF Blockers or Biologics: Concurrent use with other biologics or TNF blockers can increase the risk of infections.
• Cytochrome P450 Substrates: Yuflyma may impact the levels of these drugs.

Special Considerations for Biologic Products

Care should be taken when switching from or to other biologic products, as overlapping biological activity may increase risks.

Use in Specific Populations

Considerations for Use in Children, the Elderly, Pregnant, or Breastfeeding Women

• Children: Safety and efficacy have been established for certain conditions in pediatric patients.
• Elderly: Older patients may be more susceptible to infections.
• Pregnant Women: Yuflyma should be used during pregnancy only if clearly needed. The effects on the developing fetus are not fully known.
• Breastfeeding Women: Caution should be exercised when Yuflyma is administered to breastfeeding women, as it is not known if the drug is excreted in human milk.

Storage and Handling

Proper Storage Conditions

• Refrigeration: Yuflyma should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F).
• Protection from Light: Keep the product in the original carton until ready for use to protect it from light.
• Avoid Freezing: Do not freeze the medication.

Handling and Disposal of the Medication

• Handling: Allow the medication to reach room temperature before administration for patient comfort.
• Disposal: Used syringes and needles should be placed in a puncture-resistant container and disposed of in accordance with local regulations. Do not reuse or share syringes and needles.

Cost & Discounts for Yuflyma

Your health is a priority, and purchasing essential medication shouldn’t be prohibitively expensive. At Pharma Giant, we offer affordable and accessible healthcare solutions.

In the United States, the cost of Yuflyma can be significant. However, through Pharma Giant, patients can access more affordable pricing options:

Additionally, apply the coupon code PGSAVE10 at checkout to receive a 10% discount on your first order, making these essential medications even more affordable.

Assurance of Quality and Timely Delivery

At Pharma Giant, we are committed to providing top-tier medication and reliable delivery services right to your doorstep. Through our express shipping, you can anticipate receiving your order within just 3-5 business days across the US. Each order is meticulously packaged to ensure that your medication is protected during transit.

Please note: A prescription is required to order Yuflyma. Patients can save significantly on medication when they order online through Pharma Giant (pharmagiant.com).

Frequently Asked Questions

Disclaimer

Pharma Giant provides medical information to help you better understand medications and medical conditions.This content is for informational use only and does not replace advice from a licensed medical practitioner. Consult your doctor or pharmacist before starting or changing any medication. All our partners follow strict safety standards set by their country’s health authorities to make sure you receive safe and high-quality medications.